Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pacing failure due to flecainide acetate.

P R Walker, M Papouchado, M A James

    Pacing and Clinical Electrophysiology : PACE
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Flecainide acetate can cause a dangerous increase in pacemaker pacing thresholds, potentially leading to device failure. Caution is advised when prescribing this antiarrhythmic drug to elderly patients with pacemakers.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessing discards in an illegal small-scale fishery using fisher-led reporting.

    Reviews in fish biology and fisheries·2022
    Same author

    Probable Phaeoacremonium parasiticum as a cause of cavitary native lung nodules after single lung transplantation.

    Transplant infectious disease : an official journal of the Transplantation Society·2013
    Same author

    RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.

    The journal of the Royal College of Physicians of Edinburgh·2012
    Same author

    RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.

    The journal of the Royal College of Physicians of Edinburgh·2012
    Same author

    Immunogenicity of an interferon-beta1a product.

    International journal of immunopathology and pharmacology·2011
    Same author

    Aortic dissection: a review of the diagnosis and initial management.

    Acute medicine·2011
    Same journal

    Dual Coronary Sinus Lead Strategy to Avoid Tricuspid Valve Traversal in Biventricular Pacing.

    Pacing and clinical electrophysiology : PACE·2026
    Same journal

    A Case of Permanent Pacemaker Implantation via the Epicardial Approach Using the 3830 Lead in an 11-Day-Old Neonate (With Follow-Up of the Above Case).

    Pacing and clinical electrophysiology : PACE·2026
    Same journal

    Cryoballoon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation: Meta-Analysis of Randomized Trials.

    Pacing and clinical electrophysiology : PACE·2026
    Same journal

    Tilt Test Duration in Suspected Vasovagal Syncope: Temporal Patterns and Diagnostic Yield in Patients From Central China.

    Pacing and clinical electrophysiology : PACE·2026
    Same journal

    Combined Leadless Pacing and Subcutaneous ICD Therapy in Long QT Syndromes.

    Pacing and clinical electrophysiology : PACE·2026
    Same journal

    Association of Anesthesia Modality With Procedural Parameters and Clinical Outcomes in PVI for Atrial Fibrillation.

    Pacing and clinical electrophysiology : PACE·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Flecainide acetate is a Class 1 antiarrhythmic drug.
    • It is effective for treating ventricular and atrioventricular/nodal reentrant tachycardias.
    • Known side effect: increased pacing threshold with IV and oral administration.